Zydus Lifesciences Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported revenue was INR 56,902 million compared to INR 50,484 million a year ago. Net income was INR 11,823 million compared to INR 2,966 million a year ago. Basic earnings per share from continuing operations was INR 11.66 compared to INR 2.95 a year ago. Diluted earnings per share from continuing operations was INR 11.66 compared to INR 2.95 a year ago. Basic earnings per share was INR 11.69 compared to INR 2.93 a year ago. Diluted earnings per share was INR 11.69 compared to INR 2.93 a year ago.
For the full year, revenue was INR 198,315 million compared to INR 174,240 million a year ago. Net income was INR 38,595 million compared to INR 19,603 million a year ago. Basic earnings per share from continuing operations was INR 37.91 compared to INR 19.35 a year ago. Diluted earnings per share from continuing operations was INR 37.91 compared to INR 19.35 a year ago. Basic earnings per share was INR 38.14 compared to INR 19.3 a year ago. Diluted earnings per share was INR 38.14 compared to INR 19.3 a year ago.